SANG Fundamental Analysis - SANGOMA TECHNOLOGIES CORP

Fundamental Rating

Overall SANG gets a fundamental rating of 3 out of 10. We evaluated SANG against 48 industry peers in the Communications Equipment industry. SANG may be in some trouble as it scores bad on both profitability and health. SANG is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

SANG had negative earnings in the past year.

In the past year SANG had a positive cash flow from operations.

SANG had negative earnings in 4 of the past 5 years.

Each year in the past 5 years SANG had a positive operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -1.45%, SANG is in line with its industry, outperforming 45.83% of the companies in the same industry.

SANG has a Return On Equity (-1.97%) which is in line with its industry peers.

		Industry Rank	Sector Rank
ROA	-1.45%
ROE	-1.97%
ROIC	N/A

ROA(3y)-3.39%

ROA(5y)-6.47%

ROE(3y)-5.4%

ROE(5y)-10.77%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With an excellent Gross Margin value of 68.34%, SANG belongs to the best of the industry, outperforming 93.75% of the companies in the same industry.

SANG's Gross Margin has been stable in the last couple of years.

The Profit Margin and Operating Margin are not available for SANG so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	68.34%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.76%

GM growth 5Y1.11%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

SANG does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for SANG has been reduced compared to 1 year ago.

SANG has more shares outstanding than it did 5 years ago.

The debt/assets ratio for SANG has been reduced compared to a year ago.

2.2 Solvency

SANG has an Altman-Z score of 1.13. This is a bad value and indicates that SANG is not financially healthy and even has some risk of bankruptcy.

SANG has a Altman-Z score (1.13) which is in line with its industry peers.

The Debt to FCF ratio of SANG is 1.70, which is an excellent value as it means it would take SANG, only 1.70 years of fcf income to pay off all of its debts.

Looking at the Debt to FCF ratio, with a value of 1.70, SANG is in the better half of the industry, outperforming 66.67% of the companies in the same industry.

SANG has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.

With a Debt to Equity ratio value of 0.13, SANG perfoms like the industry average, outperforming 52.08% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.13
Debt/FCF	1.7
Altman-Z	1.13

ROIC/WACCN/A

WACC8.72%

2.3 Liquidity

A Current Ratio of 0.86 indicates that SANG may have some problems paying its short term obligations.

With a Current ratio value of 0.86, SANG is not doing good in the industry: 93.75% of the companies in the same industry are doing better.

SANG has a Quick Ratio of 0.86. This is a bad value and indicates that SANG is not financially healthy enough and could expect problems in meeting its short term obligations.

SANG has a worse Quick ratio (0.70) than 91.67% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.86
Quick Ratio	0.7

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 42.31% over the past year.

SANG shows a decrease in Revenue. In the last year, the revenue decreased by -4.28%.

SANG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.31% yearly.

EPS 1Y (TTM)42.31%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%120%

Revenue 1Y (TTM)-4.28%

Revenue growth 3Y1.79%

Revenue growth 5Y19.31%

Sales Q2Q%-2.58%

3.2 Future

The Earnings Per Share is expected to grow by 97.96% on average over the next years. This is a very strong growth

SANG is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -4.08% yearly.

EPS Next Y82.04%

EPS Next 2Y97.96%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year-12.77%

Revenue Next 2Y-4.08%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

SANG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year SANG is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

97.92% of the companies in the same industry are more expensive than SANG, based on the Enterprise Value to EBITDA ratio.

100.00% of the companies in the same industry are more expensive than SANG, based on the Price/Free Cash Flow ratio.

		Industry Rank	Sector Rank
P/FCF	5.02
EV/EBITDA	4.75

4.3 Compensation for Growth

A more expensive valuation may be justified as SANG's earnings are expected to grow with 97.96% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y97.96%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

SANG does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

SANGOMA TECHNOLOGIES CORP

NASDAQ:SANG (10/10/2025, 8:56:35 PM)

4.97

+0.06 (+1.2%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupTechnology Hardware & Equipment

GICS IndustryCommunications Equipment

Earnings (Last)09-17 2025-09-17/amc

Earnings (Next)11-05 2025-11-05

Inst Owners34.91%

Inst Owner Change0%

Ins Owners27.21%

Ins Owner ChangeN/A

Market Cap165.25M

Analysts80

Price Target7.81 (57.14%)

Short Float %0.08%

Short Ratio2.45

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)281.52%

Min EPS beat(2)-32.01%

Max EPS beat(2)595.05%

EPS beat(4)1

Avg EPS beat(4)89.5%

Min EPS beat(4)-197.03%

Max EPS beat(4)595.05%

EPS beat(8)2

Avg EPS beat(8)2.25%

EPS beat(12)5

Avg EPS beat(12)12.48%

EPS beat(16)6

Avg EPS beat(16)-258.64%

Revenue beat(2)1

Avg Revenue beat(2)-1.04%

Min Revenue beat(2)-2.42%

Max Revenue beat(2)0.34%

Revenue beat(4)1

Avg Revenue beat(4)-3.25%

Min Revenue beat(4)-7.66%

Max Revenue beat(4)0.34%

Revenue beat(8)2

Avg Revenue beat(8)-2.22%

Revenue beat(12)3

Avg Revenue beat(12)-2.89%

Revenue beat(16)7

Avg Revenue beat(16)0.74%

PT rev (1m)-6.4%

PT rev (3m)-7.55%

EPS NQ rev (1m)-8.33%

EPS NQ rev (3m)-8.33%

EPS NY rev (1m)-159.27%

EPS NY rev (3m)36.5%

Revenue NQ rev (1m)-9.25%

Revenue NQ rev (3m)-9.25%

Revenue NY rev (1m)-14.81%

Revenue NY rev (3m)-15.61%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.7
P/FCF	5.02
P/OCF	3.95
P/B	0.65
P/tB	N/A
EV/EBITDA	4.75

EPS(TTM)-0.15

EYN/A

EPS(NY)-0.03

Fwd EYN/A

FCF(TTM)0.99

FCFY19.94%

OCF(TTM)1.26

OCFY25.29%

SpS7.12

BVpS7.64

TBVpS-0.97

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-1.45%
ROE	-1.97%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	68.34%
FCFM	13.92%

ROA(3y)-3.39%

ROA(5y)-6.47%

ROE(3y)-5.4%

ROE(5y)-10.77%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.76%

GM growth 5Y1.11%

F-Score6

Asset Turnover0.68

Health

		Industry Rank	Sector Rank
Debt/Equity	0.13
Debt/FCF	1.7
Debt/EBITDA	0.78
Cap/Depr	19.62%
Cap/Sales	3.73%
Interest Coverage	N/A
Cash Conversion	95.46%
Profit Quality	N/A
Current Ratio	0.86
Quick Ratio	0.7
Altman-Z	1.13

F-Score6

WACC8.72%

ROIC/WACCN/A

Cap/Depr(3y)22.92%

Cap/Depr(5y)19.53%

Cap/Sales(3y)4.2%

Cap/Sales(5y)3.39%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)42.31%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%120%

EPS Next Y82.04%

EPS Next 2Y97.96%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-4.28%

Revenue growth 3Y1.79%

Revenue growth 5Y19.31%

Sales Q2Q%-2.58%

Revenue Next Year-12.77%

Revenue Next 2Y-4.08%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-26.22%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year2383.46%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-1.16%

FCF growth 3Y27.36%

FCF growth 5Y36.51%

OCF growth 1Y-5.56%

OCF growth 3Y25.66%

OCF growth 5Y36.31%

SANGOMA TECHNOLOGIES CORP (SANG) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens